The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 9, 2023 | Abernethy Amy | Director | Disposed to issuer(D) | 389K | — | $0 |
| Nov 9, 2023 | Meanwell Clive | Director | Disposed to issuer(D) | 101K | — | $0 |
| Nov 9, 2023 | Meanwell Clive | Director | Disposed to issuer(D) | 314K | — | $0 |
| Nov 9, 2023 | Meanwell Clive | Director | Disposed to issuer(D) | 43K | — | — |
| Nov 9, 2023 | Giusti Kathryn E | Director | Disposed to issuer(D) | 22K | — | — |
| Nov 9, 2023 | Giusti Kathryn E | Director | Disposed to issuer(D) | 101K | — | $0 |
| Nov 9, 2023 | Giusti Kathryn E | Director | Disposed to issuer(D) | 159K | — | $0 |
| Nov 9, 2023 | Conde Jorge | Director | Disposed to issuer(D) | 19.2M | — | — |
| Nov 9, 2023 | Conde Jorge | Director | Disposed to issuer(D) | 17.4M | — | — |
| Nov 9, 2023 | Conde Jorge | Director | Disposed to issuer(D) | 5.0M | — | — |
| Nov 9, 2023 | Conde Jorge | Director | Disposed to issuer(D) | 11.4M | — | — |
| Nov 9, 2023 | Conde Jorge | Director | Disposed to issuer(D) | 2.4M | — | — |
| Nov 9, 2023 | Conde Jorge | Director | Disposed to issuer(D) | 2.6M | — | — |
| Nov 9, 2023 | Conde Jorge | Director | Disposed to issuer(D) | 1.6M | — | — |
| Nov 9, 2023 | Yeshwant Krishna | Director | Disposed to issuer(D) | 101K | — | $0 |
| Nov 9, 2023 | AH Equity Partners Bio II, L.L.C. | 10% Owner | Tender(U) | 5.0M | — | — |
| Nov 9, 2023 | AH Equity Partners Bio II, L.L.C. | 10% Owner | Tender(U) | 11.4M | — | — |
| Nov 9, 2023 | AH Equity Partners Bio II, L.L.C. | 10% Owner | Tender(U) | 17.4M | — | — |
| Nov 9, 2023 | AH Equity Partners Bio II, L.L.C. | 10% Owner | Tender(U) | 12K | — | — |
| Nov 9, 2023 | AH Equity Partners Bio II, L.L.C. | 10% Owner | Tender(U) | 19.2M | — | — |
| Nov 9, 2023 | AH Equity Partners Bio II, L.L.C. | 10% Owner | Tender(U) | 2.4M | — | — |
| Nov 9, 2023 | AH Equity Partners Bio II, L.L.C. | 10% Owner | Tender(U) | 2.6M | — | — |
| Nov 9, 2023 | AH Equity Partners Bio II, L.L.C. | 10% Owner | Tender(U) | 1.6M | — | — |
| Nov 9, 2023 | Borisy Alexis | Executive Chairman, Director | Disposed to issuer(D) | 18.8M | — | — |
| Nov 9, 2023 | Borisy Alexis | Executive Chairman, Director | Disposed to issuer(D) | 2.2M | — | $0 |
| Nov 9, 2023 | Borisy Alexis | Executive Chairman, Director | Disposed to issuer(D) | 2.9M | — | — |
| Nov 9, 2023 | Andreessen Horowitz LSV Fund II-B, L.P. | 10% Owner | Tender(U) | 11.4M | — | — |
| Nov 9, 2023 | Andreessen Horowitz LSV Fund II-B, L.P. | 10% Owner | Tender(U) | 12K | — | — |
| Nov 9, 2023 | Andreessen Horowitz LSV Fund II-B, L.P. | 10% Owner | Tender(U) | 17.4M | — | — |
| Nov 9, 2023 | Andreessen Horowitz LSV Fund II-B, L.P. | 10% Owner | Tender(U) | 19.2M | — | — |
| Nov 9, 2023 | Andreessen Horowitz LSV Fund II-B, L.P. | 10% Owner | Tender(U) | 5.0M | — | — |
| Nov 9, 2023 | Andreessen Horowitz LSV Fund II-B, L.P. | 10% Owner | Tender(U) | 2.6M | — | — |
| Nov 9, 2023 | Andreessen Horowitz LSV Fund II-B, L.P. | 10% Owner | Tender(U) | 1.6M | — | — |
| Nov 9, 2023 | Andreessen Horowitz LSV Fund II-B, L.P. | 10% Owner | Tender(U) | 2.4M | — | — |
| Nov 9, 2023 | Abernethy Amy | Director | Disposed to issuer(D) | 200K | — | — |
| Nov 9, 2023 | Ciarimboli Dina | General Counsel and Secretary | Disposed to issuer(D) | 732K | — | — |
| Nov 9, 2023 | Ciarimboli Dina | General Counsel and Secretary | Disposed to issuer(D) | 575K | — | $0 |
| Nov 9, 2023 | Ciarimboli Dina | General Counsel and Secretary | Disposed to issuer(D) | 43K | — | — |
| Nov 9, 2023 | Ciarimboli Dina | General Counsel and Secretary | Disposed to issuer(D) | 157K | — | $0 |
| Nov 9, 2023 | Horning Sandra | Director | Disposed to issuer(D) | 470K | — | — |
| Nov 9, 2023 | Horning Sandra | Director | Disposed to issuer(D) | 108K | — | — |
| Nov 9, 2023 | Horning Sandra | Director | Disposed to issuer(D) | 101K | — | $0 |
| Nov 9, 2023 | Horning Sandra | Director | Disposed to issuer(D) | 314K | — | $0 |
| Nov 9, 2023 | Merksamer Samuel J. | Director | Disposed to issuer(D) | 101K | — | $0 |
| Nov 9, 2023 | Berns Paul L | Director | Disposed to issuer(D) | 627K | — | — |
| Nov 9, 2023 | Berns Paul L | Director | Disposed to issuer(D) | 101K | — | $0 |
| Nov 9, 2023 | Berns Paul L | Director | Disposed to issuer(D) | 86K | — | — |
| Nov 9, 2023 | Nallicheri Melanie | Chief Executive Officer, Director | Disposed to issuer(D) | 3.9M | — | — |
| Nov 9, 2023 | Nallicheri Melanie | Chief Executive Officer, Director | Disposed to issuer(D) | 6.3M | — | — |
| Nov 9, 2023 | Nallicheri Melanie | Chief Executive Officer, Director | Option exercise(M) | 627K | $2.21 | $1.4M |
| Nov 9, 2023 | Nallicheri Melanie | Chief Executive Officer, Director | Disposed to issuer(D) | 1.0M | — | — |
| Nov 9, 2023 | Nallicheri Melanie | Chief Executive Officer, Director | Option exercise(M) | 627K | — | $0 |
| Nov 9, 2023 | Nallicheri Melanie | Chief Executive Officer, Director | Disposed to issuer(D) | 1.3M | — | $0 |
| Nov 9, 2023 | Nallicheri Melanie | Chief Executive Officer, Director | Disposed to issuer(D) | 1.9M | — | $0 |
| Nov 9, 2023 | Nallicheri Melanie | Chief Executive Officer, Director | Disposed to issuer(D) | 530K | — | — |
| Nov 9, 2023 | Casdin Eli | 10% Owner | Other(J) | 5.5M | — | $0 |
| Nov 9, 2023 | Casdin Eli | 10% Owner | Other(J) | 30.2M | — | $0 |
| Nov 9, 2023 | Casdin Eli | 10% Owner | Other(J) | 8.7M | — | $0 |
| Nov 9, 2023 | Casdin Eli | 10% Owner | Other(J) | 3.8M | — | $0 |
| Nov 9, 2023 | Casdin Eli | 10% Owner | Other(J) | 8.1M | — | $0 |
| Nov 9, 2023 | Casdin Eli | 10% Owner | Other(J) | 3.5M | — | — |
| Nov 9, 2023 | Casdin Eli | 10% Owner | Other(J) | 101K | — | $0 |
| Nov 9, 2023 | Casdin Eli | 10% Owner | Other(J) | 756K | — | — |
| Nov 9, 2023 | Casdin Eli | 10% Owner | Other(J) | 527K | — | — |
| Jul 1, 2023 | Ciarimboli Dina | General Counsel and Secretary | Grant(A) | 575K | — | $0 |
| Jan 1, 2023 | Meanwell Clive | Director | Grant(A) | 226 | — | — |
| Jan 1, 2023 | Ciarimboli Dina | General Counsel and Secretary | Grant(A) | 226 | — | — |
| Jan 1, 2023 | Conde Jorge | Director | Grant(A) | 14K | — | — |
| Jan 1, 2023 | Conde Jorge | Director | Grant(A) | 8K | — | — |
| Jan 1, 2023 | Conde Jorge | Director | Grant(A) | 13K | — | — |
| Jan 1, 2023 | Casdin Eli | 10% Owner | Grant(A) | 3K | — | — |
| Jan 1, 2023 | Casdin Eli | 10% Owner | Grant(A) | 4K | — | — |
| Jan 1, 2023 | Casdin Eli | 10% Owner | Grant(A) | 18K | — | — |
| Jan 1, 2023 | Hedrick Eric | Chief Physician Executive | Grant(A) | 543 | — | — |
| Jan 1, 2023 | Horning Sandra | Director | Grant(A) | 565 | — | — |
| Jan 1, 2023 | Giusti Kathryn E | Director | Grant(A) | 114 | — | — |
| Jan 1, 2023 | Rubin Jami | Chief Financial Officer | Grant(A) | 2K | — | — |
| Jan 1, 2023 | Borisy Alexis | Executive Chairman, Director | Grant(A) | 15K | — | — |
| Jan 1, 2023 | Berns Paul L | Director | Grant(A) | 453 | — | — |
| Jan 1, 2023 | Nallicheri Melanie | Chief Executive Officer, Director | Grant(A) | 5K | — | — |
| Jan 1, 2023 | Nallicheri Melanie | Chief Executive Officer, Director | Grant(A) | 3K | — | — |
| Jan 1, 2023 | AH Bio Fund III-B, L.P. | 10% Owner | Grant(A) | 14K | — | — |
| Jan 1, 2023 | AH Bio Fund III-B, L.P. | 10% Owner | Grant(A) | 13K | — | — |
| Jan 1, 2023 | AH Bio Fund III-B, L.P. | 10% Owner | Grant(A) | 8K | — | — |
| Jan 1, 2023 | Andreessen Horowitz LSV Fund II-Q, L.P. | 10% Owner | Grant(A) | 13K | — | — |
| Jan 1, 2023 | Andreessen Horowitz LSV Fund II-Q, L.P. | 10% Owner | Grant(A) | 8K | — | — |
| Jan 1, 2023 | Andreessen Horowitz LSV Fund II-Q, L.P. | 10% Owner | Grant(A) | 14K | — | — |
| Sep 30, 2022 | Abernethy Amy | Director | Grant(A) | 0 | — | $0 |
| Sep 30, 2022 | Meanwell Clive | Director | Grant(A) | 101K | — | $0 |
| Sep 30, 2022 | Casdin Eli | Director, 10% Owner | Grant(A) | 101K | — | $0 |
| Sep 30, 2022 | Berns Paul L | Director | Grant(A) | 101K | — | $0 |
| Sep 30, 2022 | Merksamer Samuel J. | Director | Grant(A) | 101K | — | $0 |
| Sep 30, 2022 | Giusti Kathryn E | Director | Grant(A) | 101K | — | $0 |
| Sep 30, 2022 | Horning Sandra | Director | Grant(A) | 101K | — | $0 |
| Sep 30, 2022 | Yeshwant Krishna | Director | Grant(A) | 101K | — | $0 |
| Feb 25, 2022 | Abernethy Amy | Director | Grant(A) | 389K | — | $0 |
| Feb 25, 2022 | Ciarimboli Dina | General Counsel and Secretary | Grant(A) | 575K | — | $0 |
| Feb 25, 2022 | Hedrick Eric | Chief Physician Executive | Grant(A) | 505K | — | $0 |
| Feb 25, 2022 | Nallicheri Melanie | Chief Executive Officer, Director | Grant(A) | 1.9M | — | $0 |
| Feb 25, 2022 | Rubin Jami | Chief Financial Officer | Grant(A) | 516K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).